Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Fraternale et al., 2017
Phase 2 RCT in The Lancet : at 24 weeks, tesofensine 0.5 mg produced a mean diet-adjusted weight loss of 9.2%, and at 1.0 mg a loss of 10.6%, compared with 2.0% for diet plus placebo (p 99% (HPLC, LCMS) Documentation: Batch-specific Certificate of Analysis (COA) included Handling for Research Use Tesofensine capsules ship as a pre-encapsulated, dry oral-research format
Some key benefits include: Convenience : The weekly injection schedule makes it easier for people to stick to their treatment compared to daily injections or pills
What else you should know You've probably heard the term "Ozempic face" to describe the changed appearance of people who've lost significant amounts of weight
Studies found that more than a third of people taking Ozempic in 2023 had no history of type 2 diabetes
US$ 29.47
US$ 29.05
US$ 24.39
